Researchers Mark Castleberry, a doctoral student, and professor Sean Davidson, both in the UC College of Medicine, have found a way to produce Apolipoprotein A5 (APOA 5) protein in the laboratory. It plays an important role in metabolising and clearing excess levels of triglycerides from the bloodstream. Their findings, ‘Functional recombinant apolipoprotein A5 that is stable at high concentrations at physiological pH’, were published in the Journal of Lipid Research.
The American College of Surgeons has issued guidelines for the triage of metabolic and bariatric surgery (MBS) patients, as part of its Coronavirus Disease 2019 (COVID-19) and Surgery online resource for the surgical community facing the impact of COVID-19.
A new report on COVID-19 data to March 18 from Italy, prepared by an Italian expert for the European Society of Anaesthesiology (ESA), states that the rate of increase in the number of patients in intensive care units (ICU) with COVID-19 in Italy may have peaked in Lombardy, and may still be peaking in Italy as a whole. The report is by Davide Manca, Professor of Process Systems Engineering at Politecnico di Milano, Milan, Italy.
Elective bariatric surgery in both the NHS and private sectors will effectively cease for the next 3- 6 months to help the NHS cope with the extraordinary pressures that the coronavirus outbreak has brought.
In the midst of this organised chaos and uncertainty it’s important that we support each other, our colleagues and our patients.
According to a study by scientists at Sanford Burnham Prebys and the University of Michigan Medical School, misfolded proinsulin - a protein the body normally processes into insulin - is an early sign of type 2 diabetes. The discovery could lead to tests or treatments that help prevent people from developing type 2 diabetes.